Maternal health care in the U.S. is in crisis, especially within Medicaid, which covers over 40% of births. A new study led by HPHCI, BMC, and BUSPH explore this question and found that both primary care and health systems led models improve care, but in different ways. tinyurl.com/2u7vdmvp

🎉 Congratulations to HPHCI's researchers on their publication being selected as NIEHS Extramural Paper of the Month! Using street-level measures, researchers found that women living in areas with more greenspace had better cardiovascular health. View the study: tinyurl.com/ms8dwz7n

What do cell phone bans in U.S. public schools look like? A new study by HPHCI's Hao Yu and colleagues assessed this question. Researchers surveyed K–12 principals nationwide and found most schools limit phone use, but policies vary by grade and neighborhood. Explore the study: tinyurl.com/3978ysv3

Can Medicaid accountable care organizations (ACOs) impact maternal health care? A new study by HPHCI, BMC, and BUSPH explore this question and found that both primary care and health systems led models improve care, but in different ways. See how by diving into the full study tinyurl.com/2u7vdmvp

Can Medicaid accountable care organizations (ACOs) impact maternal health care? A new study by HPHCI, BMC, and BUSPH explore this question and found that both primary care and health systems led models improve care, but in different ways. See how by diving into the full study tinyurl.com/2u7vdmvp

#Newborn #screening in the U.S. has been a successful #publichealth program, detecting thousands of #infants who need early #treatment. With advances in #geneticsequencing and #gene‑based therapies, the number of #conditions that could qualify for #screening can increase. Read Here: buff.ly/1O45MUj

A large‐scale #study using the All of Us Research Program #data has identified common & rare #genetic #variants linked to #strabismus. Findings offer insight into the genetic pattern of strabismus, potential #treatment, and the value of #diversity in #medical #research. Read Here: buff.ly/8UqiPWv

Since 1992, we’ve been on a mission to improve health care delivery and population health. Our timeline highlights the incredible milestones we’ve achieved over the years and tells the story of our incredible growth.🌱 Check it out on our new website! tinyurl.com/y638hxe2

A new study led by HPHCI researchers lays the foundation for updating the CDC’s Adult Sepsis Event definition, enhancing its use for national quality reporting and epidemiologic monitoring. Study: tinyurl.com/4vdcr8sv See how our Sepsis Center is advancing care and research: lnkd.in/eJDQpQHF

Join us for our upcoming Research Café, featuring faculty member Izzuddin Aris who will present on “Neighborhood Vulnerability and Women’s Health - Insights from the Project Viva Cohort”. Join us to learn more about this impactful research! Event details: www.populationmedicine.org/about/events

Patients with suspected sepsis are treated with antibiotics, but this can lead to overuse and complications. A study by HPHCI researchers found many may not need such broad treatment—highlighting the need for more thoughtful guidelines that reflect diagnostic uncertainty. 🔗 tinyurl.com/vnw72xj5

#Metachromatic #leukodystrophy (#MLD) is rare—1 in 100,000 births—but devastating if missed. A new two-tier #newbornscreen can catch it early, enabling #genetherapy that improves #survival & motor #outcomes. #pediatric #genomics #rarediseases @hadleyssmith.bsky.social Read More: buff.ly/qx2xQcx

The NIH ECHO Symposium kicks off this morning, and we’re excited to see Izzuddin Aris’s present his work on how neighborhood environments shape child health outcomes. Join virtually/in person for a full day of expert insights and real-world research driving change in child health. cvent.me/8229Py

In a recent thought piece, HPHCIs Chanu Rhee and Michael Klompas explore whether current sepsis definitions are too broad—leading to aggressive treatment for patients who may not need it. They suggest refining definitions to better target those who need urgent, intensive care. tinyurl.com/5n8hyrpd

Harvard Pilgrim Health Care Institute fellow Lauren Violette is featured in a recent Q&A with Healio. She discusses findings from a national survey she and colleagues analyzed where results showed strong support for over-the-counter (OTC) HIV PrEP—especially among people who face barriers to care.

It’s official—we joined Threads 🎉 We’re excited to share our latest research, news, and events in this new space. Follow us to stay updated on the work our researchers are doing and the impact we’re making in #populationhealth tinyurl.com/3zym98bb

The NIH Environmental influences on Child Health Outcomes (ECHO) Symposium is one week away! We’re excited to share that Izzuddin Aris will be presenting his work on how neighborhood environments impact child health. 📅 Sept.15, 2025 ⏰ 9-5 PM ET 📍 In person/Teams (FREE) Register: 🔗 cvent.me/8229Py

Treating sepsis quickly with antibiotics is critical—but does the order in which they’re given make a difference? HPHCI’s researchers explored this question and found that giving β-lactams before vancomycin was associated with lower mortality in patients with sepsis. Study: tinyurl.com/3tv49ec8

Sepsis is a life-threatening condition that affects over a million people in the U.S. Raising awareness is critical and can help save lives. At HPHCI, our researchers are working to advance how we treat and prevent sepsis. Join us this month as we share their work and its meaningful impact.

U.S. newborn screening is entering a new era, marked by the promise of genomic technologies and absence of a key national guidance committee. @mattmotta.bsky.social and I discuss recent events in the newborn screening policy space in a new JAMA Pediatrics Viewpoint. jamanetwork.com/journals/jam...

In 2024, Hurricane Helene triggered a nationwide shortage of IV fluids after hitting a facility that produced 60% of the country’s supply. It wasn’t the first time extreme weather disrupted the U.S drug supply.

Newborn screening (NBS) saves thousands of lives each year and new genetic advances could help detect even more conditions. But with the 2025 shutdown of the ACHDNC, states now face complex decisions without national guidance.

Looking forward to participating in this webinar to discuss our work on distributional cost-effectiveness analysis in genomic medicine, recently published in Value in Health www.sciencedirect.com/science/arti...

Highlighting our LGBTQ Health Center of Excellence. They are one of five centers of excellence at HPHCI, advancing population health.

New paper! CHeRP faculty @wrightcensored.bsky.social and peers' paper Shifts in U.S. #Pediatric #Obesity #Treatment After the AAP Guidelines is featured in Pediatrics! Read More Here: buff.ly/6gfJvvG

Highlighting our Center for Sepsis Epidemiology and Prevention Studies (SEPSIS) SEPSIS is one of five centers of excellence at HPHCI, advancing population health.

Congratulations to HPHCI's @hadleyssmith.bsky.social or her latest publication being selected for Value in Health’s "Editor's Choice" for August 2025! 🎉 Thank you to ISPOR—The Professional Society for Health Economics and Outcomes Research for highlighting this impactful work.

New article! CHeRP faculty Isdin Oke and team's paper Association of #Childhood #Neighborhood Opportunity with #Retinopathy of Prematurity Neighborhood Opportunity and Retinopathy of Prematurity is featured in Am J Ophthalmol! Read more here: buff.ly/zZQFStC

Highlighting our Precision Medicine Translational Research Center (PROMoTeR) PROMoTeR is one of five centers of excellence at HPHCI, advancing population health.

Harvard Pilgrim Health Care Institute’s Davene R. Wright joins the American Academy of Pediatrics (AAP) podcast Pediatrics on Call to discuss her recent paper.

Highlighting our Center for Cancer Policy and Program Evaluation (CarPE) CarPE is one of five centers of excellence at HPHCI, advancing population health.

A new study published in the JAMA Network Open, by HPHCI’s Hao Yu and colleagues, examined #mentalhealth screening practices in U.S public schools.

New paper! @hadleyssmith.bsky.social and team's paper An end to #genetic exceptionalism: reframing the #ethics of #genomicsequencing for rapid #neonatal #diagnosis is featured in Semin Perinatol! Read More Here: buff.ly/Zh7Js2G

Highlighting our Center for AI and Biomedical Informatics (CAB) CAB is 1 of 5 centers of excellence at HPHCI, advancing population health.

A new study led by Harvard Pilgrim Health Care Institute’s @wrightcensored.bsky.social in collaboration with Truveta, shows a sharp increase in prescriptions for treating pediatric obesity after new guidelines were released in 2023 from the American Academy of Pediatrics. Study: tinyurl.com/4a2dfcdf

Highlighting our Division of Therapeutics Research and Infectious Disease Epidemiology (TIDE) is 1 of 5 research divisions at HPHCI, contributing to health research.

Congratulations to 2025's Harvard Pilgrim Health Care Institute Robert H. Ebert Fellowship recipient, Dongdong Li!

CHeRP faculty Kurt Christensen and colleagues' paper Opportunities amid complexities in returning #genetic results to black #precisionmedicine #research participants: Interview themes in context with open all of us #data is featured in J Clin Transl Sci! Read More Here: buff.ly/Ufn8yeN

The Division of Health Policy and Insurance Research (HPI) is 1 of 5 research divisions at HPHCI, contributing to health research. Their research efforts improve availability, access, affordability, appropriateness, and equity of health care and health outcomes. View their page: tinyurl.com/4226mku9

To help address the shortage of infectious disease physicians, the Centers for Medicare and Medicaid Services introduced a new plan to raise ID physician pay by ~20% in 2025. A new study by Harvard Pilgrim Health Care Institute researchers finds the move promising but calls for further action.

With the highest maternal mortality rate of all other high-income countries, the U.S. is facing a #maternalhealth crisis. If not addressed with evidence-based, sound solutions, this crisis will continue.

Congratulations to this year’s Gordon Moore Award for Excellence in Mentoring winners: Meg Scholl & Rui Wang! The award was established in 2019 to celebrate the outstanding Institute members who inspire, support, & catalyze the personal & professional development of colleagues. tinyurl.com/3sr7dmcs

A new study by Harvard Pilgrim Health Care Institute's researchers analyzes the Centers for Medicare and Medicaid Services (CMS) new incentive for infectious disease physicians & offers three key recommendations to guide CMS in implementing and evaluating this new payment model. tinyurl.com/ywmjxdmv

Join us for our upcoming Research Café, featuring Dr. Jeffrey Brown, who will present on “Leveraging TriNetX Data for Collaborative Research”. This event is hybrid and open to everyone! Event details: www.populationmedicine.org/about/events

The Division of Chronic Disease Research Across the Lifecourse is 1 of 5 research divisions at HPHCI, contributing to health research. Their goal is to cultivate a collaborative community that conducts research to prevent chronic disease across the lifecourse. View their page: tinyurl.com/2fz7yaad

A new publication HPHCI’s Chanu Rhee and Michael Klompas, reviews the most effective strategies to prevent COVID-19 and other hospital acquired respiratory infections. They emphasize the importance of flu and COVID-19 vaccinations and masking in hospitals to reduce infections. tinyurl.com/yc47np74

The @cherpdpm.bsky.social‬ is 1 of 5 research divisions at HPHCI, contributing to health research. Their work focuses on conditions affecting child health, using approaches like machine learning, epidemiology, health economics and more. View their page: tinyurl.com/4xj9rbs3

A new study led by HPHCI’s Soren Harnois-Leblanc, Emily Oken, & Marie-France Hivert explores how adiponectin levels from birth to late adolescence relate to insulin resistance in late adolescence, including whether these associations differ between sex. Read the full study: tinyurl.com/mrepn2uw

The Division of Biostatistics is 1 of 5 research divisions at HPHCI, contributing to health research. Their team develops statistical methods, analyzes population health data, and collaborates on study design with researchers across the scientific community. View their page: tinyurl.com/4v85yvjd

Researchers at HPHCI outline key factors in studying lecanemab's safety and usage in early-stage Alzheimer's patients. Using real-world data and target trial emulation they aim to reduce bias and provide reliable insights to help doctors and patients. tinyurl.com/3eu6228j